SeaStar Medical Holding Statistics
Total Valuation
ICU has a market cap or net worth of $36.69 million. The enterprise value is $35.72 million.
| Market Cap | 36.69M |
| Enterprise Value | 35.72M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, after market close.
| Earnings Date | Aug 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ICU has 4.17 million shares outstanding. The number of shares has increased by 415.18% in one year.
| Shares Outstanding | 4.17M |
| Shares Change (YoY) | +415.18% |
| Shares Change (QoQ) | +209.67% |
| Owned by Insiders (%) | 8.55% |
| Owned by Institutions (%) | 4.15% |
| Float | 2.93M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 88.59 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.68
| Current Ratio | 0.68 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -41.56 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -850.50% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.81M |
| Employee Count | 12 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -34.73% in the last 52 weeks. The beta is -1.05, so ICU's price volatility has been lower than the market average.
| Beta (5Y) | -1.05 |
| 52-Week Price Change | -34.73% |
| 50-Day Moving Average | 7.81 |
| 200-Day Moving Average | 14.43 |
| Relative Strength Index (RSI) | 54.54 |
| Average Volume (20 Days) | 75,819 |
Short Selling Information
The latest short interest is 121,906, so 2.92% of the outstanding shares have been sold short.
| Short Interest | 121,906 |
| Short Previous Month | 231,840 |
| Short % of Shares Out | 2.92% |
| Short % of Float | 4.16% |
| Short Ratio (days to cover) | 0.17 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -13.58M |
| Pretax Income | -33.67M |
| Net Income | -33.67M |
| EBITDA | -32.88M |
| EBIT | -32.88M |
| Earnings Per Share (EPS) | -$25.00 |
Balance Sheet
The company has $5.02 million in cash and $4.06 million in debt, giving a net cash position of $962,000 or $0.23 per share.
| Cash & Cash Equivalents | 5.02M |
| Total Debt | 4.06M |
| Net Cash | 962,000 |
| Net Cash Per Share | $0.23 |
| Equity (Book Value) | -4.47M |
| Book Value Per Share | -1.07 |
| Working Capital | -3.11M |
Cash Flow
| Operating Cash Flow | -11.48M |
| Capital Expenditures | n/a |
| Free Cash Flow | -11.48M |
| FCF Per Share | -$4.28 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ICU does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -415.18% |
| Shareholder Yield | -415.18% |
| Earnings Yield | -91.77% |
| FCF Yield | -31.29% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on June 10, 2024. It was a reverse split with a ratio of 1:25.
| Last Split Date | Jun 10, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |